Cargando…
Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Genetic variations play an important role in the clinical presentation and progression of Alzheimer’s disease (AD), especially early-onset Alzheimer’s disease. Hundreds of mutations have been reported with the majority resulting from alterations in β-amyloid precursor protein (APP), presenilin 1 (PS...
Autores principales: | Giau, Vo Van, Lee, Hyon, Shim, Kyu Hwan, Bagyinszky, Eva, An, Seong Soo A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808714/ https://www.ncbi.nlm.nih.gov/pubmed/29445268 http://dx.doi.org/10.2147/CIA.S155145 |
Ejemplares similares
-
Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
por: Bagyinszky, Eva, et al.
Publicado: (2020) -
Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2019) -
Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019) -
COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
por: Vo, Giau Van, et al.
Publicado: (2022) -
Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
por: Vo, Van Giau, et al.
Publicado: (2020)